The PANRE is a recertification exam, so this plan assumes a working clinical base and focuses on refreshing breadth, catching drift from current guidelines, and shoring up systems outside your day-to-day practice. Practice-heavy and flexible — compress or stretch the weeks to fit your schedule around work.
How to use this plan
Lead with the systems you see least in practice — that's usually where recertifying PAs lose the most points.
Daily: ~30–50 practice questions around your work schedule, read every explanation, and log what you miss.
Use questions to surface guideline drift — first-line therapies and screening intervals change, so trust the current explanation over memory.
Finish each week with a short timed, mixed block, and use analytics to keep steering time toward weak systems.
The 4-week refresh schedule
Week 1 · Cardiovascular + Pulmonary
Refresh guideline-driven care: hypertension targets and first-line agents, heart failure therapy, arrhythmias; asthma/COPD step-up, pneumonia, and PE workup.
Week 2 · GI + Renal/GU + Endocrine
GI bleed, IBD, hepatobiliary; AKI vs CKD, electrolytes, acid–base; diabetes, thyroid, and adrenal disorders with current first-line treatment.
Week 3 · MSK + Neuro + Derm + EENT
The acute joint, fractures, low back pain; stroke, seizures, headache; common rashes and skin-cancer recognition; high-yield eye/ENT complaints.
Week 4 · Psych + ID + Repro + weak systems
DSM-5 criteria and psychopharmacology; sepsis, antibiotics, STIs; contraception and prevention. Then circle back to your two weakest systems from analytics and simulate with timed, mixed blocks.
Try 3 free practice questions
A mix of organ systems from the clinician-reviewed FirstPassPA bank, each with the correct answer and a full explanation. Attempt each one before you reveal the answer.
Question 1ReproductiveMedium
A 26-year-old woman presents with sudden unilateral pelvic pain, vaginal spotting, and 7 weeks of amenorrhea. Beta-hCG is 2,800 mIU/mL. Transvaginal ultrasound shows no intrauterine pregnancy and a 2.5-cm right adnexal gestational sac with a yolk sac, separate from the ovary, with no embryonic cardiac activity and no free fluid. She is hemodynamically stable, and her CBC, creatinine, and liver enzymes are normal. What is the management?
AMethotrexate 50 mg/m2 IM
BDilation and curettage
CVaginal misoprostol
DMifepristone 200 mg orally
ERepeat beta-hCG in 48 hours
Reveal answer & full explanation
Correct answer: A — Methotrexate 50 mg/m2 IM
AMethotrexate 50 mg/m2 IM✓
BDilation and curettage
CVaginal misoprostol
DMifepristone 200 mg orally
ERepeat beta-hCG in 48 hours
Why Methotrexate 50 mg/m2 IM is correct
An extrauterine gestational sac with a yolk sac and no intrauterine pregnancy (IUP) on transvaginal ultrasound (TVUS) confirms a tubal ectopic pregnancy, whatever the hCG level
Methotrexate is appropriate when criteria are met: hemodynamic stability, no rupture, hCG below 5,000 mIU/mL, ectopic mass below 3.5 cm, no fetal cardiac activity, and normal renal/hepatic/CBC labs; this patient is stable with an hCG of 2,800 mIU/mL, a 2.5-cm unruptured mass without cardiac activity, and normal labs
Why the others are wrong
Repeat beta-hCG in 48 hours — serial hCG is for a pregnancy of unknown location; here the ectopic is already visualized, so waiting only delays treatment and risks rupture
Dilation and curettage — does not treat a tubal ectopic pregnancy
Vaginal misoprostol — a uterotonic that expels an intrauterine gestation; it has no effect on trophoblast implanted in the tube and leaves the ectopic in place to rupture
Mifepristone 200 mg orally — a progesterone-receptor antagonist that, paired with misoprostol, is used for medication abortion and early pregnancy loss; it acts on an intrauterine gestation, and its label lists confirmed or suspected ectopic pregnancy as a contraindication because it does not end a tubal pregnancy, leaving the ectopic in place to rupture
Additional high-yield points
Without a visualized ectopic, an empty uterus at hCG 2,800 mIU/mL is a pregnancy of unknown location: ACOG sets the discriminatory level conservatively high (up to about 3,500 mIU/mL) and does not recommend presumptive methotrexate, which is teratogenic if a viable IUP is present
A 30-year-old female has a history of recurrent depressive episodes and a single episode of decreased need for sleep, increased goal-directed activity, and elevated mood lasting 5 days that did not require hospitalization. Which of the following is the most likely diagnosis?
AMajor depressive disorder, recurrent
BCyclothymic disorder
CBipolar II disorder
DMajor depressive disorder with mixed features
EBipolar I disorder
Reveal answer & full explanation
Correct answer: C — Bipolar II disorder
AMajor depressive disorder, recurrent
BCyclothymic disorder
CBipolar II disorder✓
DMajor depressive disorder with mixed features
EBipolar I disorder
Why bipolar II disorder is correct
Bipolar II disorder requires at least one major depressive episode plus at least one hypomanic episode
Hypomania is defined as lasting >=4 days, being less severe than mania, occurring without psychosis or hospitalization, and being observable to others
This patient's episode (decreased need for sleep, increased goal-directed activity, elevated mood for 5 days, no hospitalization) meets hypomanic — not manic — criteria
Why the others are wrong
Bipolar I disorder — Bipolar I requires at least one manic episode (>=7 days, OR requiring hospitalization, OR with psychotic features); this patient's elevated-mood episode was 5 days with no hospitalization or psychosis
Cyclothymic disorder — Cyclothymic disorder requires 2+ years of hypomanic and depressive symptoms that do not meet full criteria for hypomanic or major depressive episodes
Major depressive disorder with mixed features — Major depressive disorder (MDD) with mixed features describes a depressive episode with some manic-like features, which does not account for a distinct hypomanic episode
Major depressive disorder, recurrent — recurrent MDD is a common misdiagnosis in bipolar II because patients usually seek care while depressed and hypomania goes unrecognized, but a lifetime hypomanic episode not attributable to a substance or another medical condition, such as this 5-day episode, excludes MDD and, together with her major depressive episodes and no history of mania, establishes bipolar II
Additional high-yield points
Treatment options include mood stabilizers: lithium, lamotrigine (particularly for bipolar II (BPII) depression), valproate, and atypical antipsychotics
Question 3Infectious DiseaseMedium
A 68-year-old male with COPD develops fever, productive cough, and new right lower lobe consolidation on hospital day 6 of an admission for a COPD exacerbation. WBC is 22K. No methicillin-resistant Staphylococcus aureus (MRSA) or Pseudomonas risk factors are identified. Which of the following empiric antibiotic regimens is most appropriate?
AAmoxicillin-clavulanate
BPiperacillin-tazobactam
CIntravenous ertapenem
DCeftriaxone plus azithromycin
EIntravenous moxifloxacin
Reveal answer & full explanation
Correct answer: B — Piperacillin-tazobactam
AAmoxicillin-clavulanate
BPiperacillin-tazobactam✓
CIntravenous ertapenem
DCeftriaxone plus azithromycin
EIntravenous moxifloxacin
Why Piperacillin-tazobactam is correct
New consolidation arising on hospital day 6 (onset >48 hours after admission) defines hospital-acquired pneumonia (HAP)
Per the 2016 IDSA/ATS HAP/VAP guideline, empiric therapy must cover gram-negative pathogens including Pseudomonas aeruginosa, so a single anti-pseudomonal beta-lactam is appropriate when MRSA and double-Pseudomonas-coverage criteria are not met
Piperacillin-tazobactam, cefepime, imipenem, and meropenem are the guideline's anti-pseudomonal beta-lactam options for this low-risk HAP scenario
Why the others are wrong
Amoxicillin-clavulanate — lacks the anti-pseudomonal activity required for HAP empiric therapy (right-setting-wrong-spectrum)
Ceftriaxone plus azithromycin — a community-acquired pneumonia regimen that does not cover Pseudomonas aeruginosa and is inappropriate for nosocomial-onset disease (confused-with CAP)
Intravenous ertapenem — unlike imipenem and meropenem, ertapenem lacks reliable activity against Pseudomonas aeruginosa, and empiric HAP coverage must include Pseudomonas even when risk factors for resistant organisms are absent, so it is not among the guideline's empiric options (right-class-wrong-spectrum)
Intravenous moxifloxacin — a respiratory fluoroquinolone with strong activity against typical and atypical community-acquired pneumonia pathogens, but unlike levofloxacin and ciprofloxacin it lacks reliable activity against Pseudomonas aeruginosa, so it does not provide the anti-pseudomonal coverage that empiric HAP therapy requires (right-class-wrong-agent)
Additional high-yield points
Most HAP is treated for 7 days, with de-escalation guided by culture data
Procalcitonin trends can help shorten antibiotic duration
The obsolete HCAP category is no longer used; prior hospitalization alone does not define HAP
That's 3 of 7,700+. Get the rest.
Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.
Studying the systems you already practice daily while neglecting the ones you rarely see.
Trusting memory on first-line therapy and screening intervals instead of confirming current guidelines.
Reading review books passively rather than testing yourself with questions.
Skipping timed, mixed practice until the final days.
Underestimating breadth — the PANRE spans the whole blueprint, not just your specialty.
Run this plan on FirstPassPA
7,700+ board-style questions, spaced repetition that follows this schedule for you, an AI tutor on every answer, and a readiness score so you know when you're ready. Free to start — no card.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.